Revised TN categorization for colon cancer based on national survival outcomes data.
about
Clinical management of localized colon cancer with capecitabineThe biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized careTNM staging of colorectal cancer should be reconsidered by T stage weightingEffects of Hospital Type and Distance on Lymph Node Assessment for Colon Cancer Among Metropolitan and Nonmetropolitan Patients in Appalachia.Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial.Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancerThe concentrations of EGFR, LRG1, ITIH4, and F5 in serum correlate with the number of colonic adenomas in ApcPirc/+ ratsTest of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.Genomic Profiling in Gastrointestinal Cancer: Are We Ready To Use These Data to Make Treatment Decisions?Neuroendocrine differentiation is predictive of poor survival in patients with stage II colorectal cancer.Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomesThe association of p53 expression levels with clinicopathological features and prognosis of patients with colon cancer following surgeryCathepsinĀ B expression in colorectal cancer in a Middle East population: Potential value as a tumor biomarker for late disease stages.Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancerSolitary lymph node metastasis is a distinct subset of colon cancer associated with good survival: a retrospective study of surveillance, epidemiology, and end-results population-based data.Association of primary tumor lymph node ratio with burden of liver metastases and survival in stage IV colorectal cancer.The prognostic value of lymph node yield in the earliest stage of colorectal cancer: a multicenter cohort studyMedullary carcinoma of the large intestine: a population based analysis.Colorectal cancers mimic structural organization of normal colonic crypts.Multidisciplinary treatment of rectal cancer in 2014: where are we going?Tissue-based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer.Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base.Phospholipid ether analogs for the detection of colorectal tumors.Is the prediction of prognosis not improved by the seventh edition of the TNM classification for colorectal cancer? Analysis of the surveillance, epidemiology, and end results (SEER) database.Comparative economics of a 12-gene assay for predicting risk of recurrence in stage II colon cancerReview of histopathological and molecular prognostic features in colorectal cancerT4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy.Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581PIK3CA mutations predict recurrence in localized microsatellite stable colon cancerMolecular profiling of colon tumors: the search for clinically relevant biomarkers of progression, prognosis, therapeutics, and predispositionGRP78 promoter polymorphism rs391957 as potential predictor for clinical outcome in gastric and colorectal cancer patients.CT predictors of overall survival at initial diagnosis in patients with stage IV colorectal cancer.Prognostic Significance of Lymph Node Ratio in Stage III Rectal Cancer.Challenges in the management of stage II colon cancerSpecific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancerEffectiveness of Adjuvant Chemotherapy with 5-FU/Leucovorin and Prognosis in Stage II Colon Cancer.Lymph node harvest in colon and rectal cancer: Current considerationsOverall Survival of Stage III Colon Cancer with Only One Lymph Node Metastasis Is Independently Predicted by Preoperative Carcinoembryonic Antigen Level and Lymph Node Sampling Status.Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trialGenetics, diagnosis and management of colorectal cancer (Review).
P2860
Q24611758-E93656E1-28FA-4789-A9D2-D742202E2480Q28066460-B9348260-A699-4279-91AD-CBF480717378Q28658050-F055CF85-50FB-495A-89B7-EC5494C0AF10Q30278008-D2DFE00C-6151-45CC-BBEA-09C8F3BECF07Q30409533-8782DF1A-C30B-4BEE-B4AD-2AB60864B9BDQ30422446-38F76483-AAD9-441B-825A-0DC2D76E2C5BQ30596947-FB0F487E-62BA-43D5-B3D8-1BADB438C30FQ30854540-992A7536-ACFC-4839-B3E3-3FD37283078DQ31012680-D2A1D0FE-764C-4DC7-A847-1A25365BBEB9Q33599071-B4384CD7-38AD-4FD1-B5AC-62B4A6CFBBB2Q33627785-5C9291A2-82E6-407D-B67F-5F638FC36B92Q33684362-06B42352-FF54-490D-A937-2A6951E33D2FQ33721128-E284F9B8-33E5-40A1-8DC5-C512888AD665Q33750119-58043EDE-CC1D-4036-8FE7-4221E9459E2FQ33805598-FF83A58E-4DD7-4201-A00F-A6E5AC4CA75DQ33809520-623BD77B-6631-4033-AC4C-369A8D996417Q33908938-D5CEA607-2A32-42CF-A108-849EC8B8FD3AQ34024561-A50A8479-CBBB-40EF-8B35-71A509A4C5E7Q34027850-4F25B9FC-244D-4C1B-9152-CC767B2D5CCEQ34093825-DC21FA65-2002-4397-B618-A715F09974D2Q34202435-0CBC50A8-1A7E-428B-AF0F-A75E975FA573Q34220627-F652D0F9-283A-4206-9D2A-53166EC649B3Q34294317-4E88FABA-B4EA-4F8F-8D25-8C255A59D37DQ34333202-D6818FA7-D5DA-4D76-923C-1E6FD62F08F1Q34573853-75DEB437-C2E5-4976-9549-E0D1629CD7DDQ34657323-9E23537A-8CE3-4E87-9380-8A8AE720692CQ35108491-E08DFF7E-1524-41D0-99ED-28CCC7130CAAQ35170266-C2013C1E-DB42-4E8C-AAC5-D1F470BC3743Q35236785-4DD7AB34-9887-480B-A904-830471559A70Q35246828-53C49A1E-6CFB-4662-9F89-87DD2994C417Q35432445-7B8CE87C-51EC-407B-9147-6665BFA71B74Q35470023-6BA8FBBA-5C8E-4DE3-B29A-520E7B893B1CQ35555663-82818C74-9C2B-4A3E-B404-C6EAA5351B63Q35622839-334F88AD-0AA8-4E66-8C62-0E22345CAE8BQ35653762-6E4E28E2-ACC6-4F7F-8E19-EA567F13F40AQ35675831-0DBB69C4-7063-4A16-B341-2CB8752F5F32Q35752056-D49ED087-F735-4913-A4C5-24D02937CB85Q35779359-9E97E8D5-8DCD-421E-917F-A5160B33FEC2Q35859030-1F2BD24E-D14B-463D-ABD3-005C4C6AC085Q35934455-CCAC0F21-B435-40E6-9160-DEF7DE487302
P2860
Revised TN categorization for colon cancer based on national survival outcomes data.
description
2009 nĆ® lÅ«n-bĆ»n
@nan
2009 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« ÕÕøÕµÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2009 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ¶ÕøÕµÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2009幓ć®č«ę
@ja
2009幓č«ę
@yue
2009幓č«ę
@zh-hant
2009幓č«ę
@zh-hk
2009幓č«ę
@zh-mo
2009幓č«ę
@zh-tw
2009幓č®ŗę
@wuu
name
Revised TN categorization for colon cancer based on national survival outcomes data.
@ast
Revised TN categorization for colon cancer based on national survival outcomes data.
@en
Revised TN categorization for colon cancer based on national survival outcomes data.
@nl
type
label
Revised TN categorization for colon cancer based on national survival outcomes data.
@ast
Revised TN categorization for colon cancer based on national survival outcomes data.
@en
Revised TN categorization for colon cancer based on national survival outcomes data.
@nl
prefLabel
Revised TN categorization for colon cancer based on national survival outcomes data.
@ast
Revised TN categorization for colon cancer based on national survival outcomes data.
@en
Revised TN categorization for colon cancer based on national survival outcomes data.
@nl
P2093
P2860
P356
P1476
Revised TN categorization for colon cancer based on national survival outcomes data.
@en
P2093
Andrew K Stewart
Frederick L Greene
John Milburn Jessup
Leonard L Gunderson
P2860
P304
P356
10.1200/JCO.2009.24.0952
P407
P577
2009-11-30T00:00:00Z